Actively Recruiting
Renal Cancer Detection With Liquid Biopsy
Led by Zealand University Hospital · Updated on 2024-01-30
200
Participants Needed
1
Research Sites
313 weeks
Total Duration
On this page
Sponsors
Z
Zealand University Hospital
Lead Sponsor
L
Lund University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Glycosaminoglycans (GAGs) were significantly altered in localized as well advanced RCC compared to healthy samples. In addition, GAG scores correlated with progression-free survival and overall survival (OS) in a prospective cohort of patients with metastatic ccRCC and localized RCC. However, it is still unknown whether alterations in plasma and urine GAGs are exquisitely specific to RCC or are shared by other benign lesions in the kidney, such as angiomyolipomas, oncocytomas, or PEComa.
CONDITIONS
Official Title
Renal Cancer Detection With Liquid Biopsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with CT scan suspicion of renal tumor showing no signs of renal cancer
- Histological confirmation of clear cell renal cell carcinoma or oncocytoma by biopsy or surgical specimen
- Signed informed consent
- Ability to undergo study procedures
You will not qualify if you...
- Non-clear cell renal cell carcinoma
- Renal cell carcinoma with pure sarcomatoid differentiation (kidney sarcoma)
- Use of heparin for active diseases requiring blood thinning such as deep vein thrombosis or lung embolism (heparin use for thrombus prevention within 4 weeks after primary surgery is allowed)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zealand University Hospital
Roskilde, Denmark, 4000
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here